No connection

Search Results

Markets Score 35 Bearish

StubHub Shares Tumble 35% in March Amid Earnings Disappointment and Revenue Decline

Apr 06, 2026 18:36 UTC
STUBH, ^GSPC
Short term

StubHub's stock fell sharply in March following a revenue drop and missed earnings expectations in its second quarterly report since going public. Management cited industry challenges and regulatory concerns as factors affecting performance.

  • StubHub's stock fell 34.8% in March after missing revenue and earnings expectations.
  • Fourth-quarter revenue declined 15.8% to $449.2 million, with adjusted losses of ($0.05) per share.
  • Management cited challenges including the absence of major events and regulatory scrutiny of secondary-market scalping.
  • StubHub's 2026 guidance forecasts 9% GMV growth and nearly doubled adjusted EBITDA to $410 million.
  • The company's stock is now trading at around eight times forward EBITDA, significantly below its IPO price.
  • StubHub's full-year 2025 GMV grew 6% despite the end of the Taylor Swift Eras tour in 2024.

Shares of StubHub (NYSE: STUB) plummeted 34.8% in March as the company reported disappointing fourth-quarter results in its second earnings report since its September 2024 initial public offering. Revenue declined 15.8% year-over-year to $449.2 million, with adjusted losses per share of ($0.05), both falling short of market expectations. The drop was attributed to a combination of industry headwinds, including the absence of high-demand events like Taylor Swift's Eras tour and the shift to 'all-in' ticket pricing mandated by the Federal Trade Commission in May 2025. Management also signaled that direct ticketing revenue, a key growth area, would not see significant contributions in 2026, and acknowledged regulatory scrutiny of secondary-market 'scalping' practices, which account for 10% of the company's gross merchandise volume (GMV). Despite the near-term challenges, StubHub reported full-year 2025 underlying GMV growth of 6%, excluding the impact of the Taylor Swift tour's conclusion. The company also provided 2026 guidance, forecasting 9% GMV growth and adjusted EBITDA to nearly double to $410 million. With its stock down nearly 75% from the IPO price of $23.50 to just above $6, investors are now evaluating whether the current valuation, trading at around eight times forward EBITDA, reflects a potential turnaround in the company's performance.

Sign up free to read the full analysis

Create a free account to unlock full AI-curated market articles, personalized alerts, and more.

Create Free Account Already have an account? Sign In
Share this article

Related Articles

Score 35 Bullish

Franklin Templeton reports $1.68 trillion AUM with $5B inflows

Apr 06, 20:57

Score 25

Form 144 Kiniksa Pharmaceuticals International For: 6 April

Apr 06, 20:57

Score 65 Bullish

US finalizes 2.48% Medicare Advantage payment hike; insurance stocks surge

Apr 06, 20:55

Score 25

Neuronetics CFO Steven Pfanstiel to depart; company begins search for successor

Apr 06, 20:41

Stay Ahead of the Markets

Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.

Get Started Free View Plans
Features Terminal AI Assistant Analysis Market News Pricing
Start Trading with AI Already have an account? Sign In
Home
Terminal
AI
Markets
Profile